US Bancorp’s Alexion Pharmaceuticals ALXN Stock Holding History

US Bancorp’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-18,327	Closed	-$3.37M	–	4251
2021 Q2	$3.37M	Sell	18,327 -9,451	-34%	-$1.62M	0.01%	698
2021 Q1	$4.25M	Sell	27,778 -2,782	-9%	-$430K	0.01%	595
2020 Q4	$4.78M	Sell	30,560 -208	-0.7%	-$26.7K	0.01%	549
2020 Q3	$3.52M	Sell	30,768 -375	-1%	-$40.5K	0.01%	572
2020 Q2	$3.5M	Sell	31,143 -1,324	-4%	-$141K	0.01%	570
2020 Q1	$2.92M	Sell	32,467 -2,349	-7%	-$231K	0.01%	568
2019 Q4	$3.77M	Sell	34,816 -761	-2%	-$81.4K	0.01%	594
2019 Q3	$3.48M	Buy	35,577 +172	+0.5%	+$19.4K	0.01%	597
2019 Q2	$4.64M	Sell	35,405 -923	-3%	-$119K	0.01%	534
2019 Q1	$4.91M	Sell	36,328 -3,400	-9%	-$423K	0.01%	501
2018 Q4	$3.87M	Sell	39,728 -635	-2%	-$75.1K	0.01%	525
2018 Q3	$5.61M	Buy	40,363 +6,696	+20%	+$840K	0.02%	474
2018 Q2	$4.18M	Buy	33,667 +2,567	+8%	+$300K	0.01%	552
2018 Q1	$3.47M	Buy	31,100 +933	+3%	+$112K	0.01%	598
2017 Q4	$3.61M	Sell	30,167 -1,577	-5%	-$192K	0.01%	593
2017 Q3	$4.45M	Buy	31,744 +3,607	+13%	+$490K	0.01%	521
2017 Q2	$3.42M	Sell	28,137 -11,045	-28%	-$1.29M	0.01%	584
2017 Q1	$4.75M	Sell	39,182 -1,177	-3%	-$152K	0.02%	496
2016 Q4	$4.94M	Sell	40,359 -6,025	-13%	-$737K	0.02%	469
2016 Q3	$5.68M	Sell	46,384 -2,751	-6%	-$354K	0.02%	435
2016 Q2	$5.74M	Buy	49,135 +5,813	+13%	+$825K	0.02%	417
2016 Q1	$6.03M	Sell	43,322 -7,321	-14%	-$1.07M	0.02%	412
2015 Q4	$9.66M	Sell	50,643 -2,156	-4%	-$377K	0.04%	333
2015 Q3	$8.26M	Sell	52,799 -5,973	-10%	-$1.09M	0.03%	361
2015 Q2	$10.6M	Buy	58,772 +5,342	+10%	+$922K	0.04%	324
2015 Q1	$9.26M	Sell	53,430 -2,623	-5%	-$475K	0.04%	348
2014 Q4	$10.4M	Buy	56,053 +611	+1%	+$113K	0.04%	330
2014 Q3	$9.19M	Buy	55,442 +5,680	+11%	+$933K	0.04%	334
2014 Q2	$7.78M	Buy	49,762 +2,394	+5%	+$378K	0.03%	365
2014 Q1	$7.21M	Buy	47,368 +2,042	+5%	+$325K	0.03%	370
2013 Q4	$6.02M	Buy	45,326 +817	+2%	+$98K	0.02%	382
2013 Q3	$5.17M	Sell	44,509 -2,035	-4%	-$223K	0.02%	401
2013 Q2	$4.29M	Buy	+46,544	New	+$4.49M	0.02%	416

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return